capstone discussion – 2 years ago
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →capstone discussion
– 2 years ago
Describe your clinical experience for this week with pediatric patients. – Did you face any challenges, any success? If so, what were they? – Describe the assessment of a patient, detailing the signs and symptoms (S&S), assessment, plan of care, and at least 3 possible differential diagnosis with ra…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →Describe your clinical experience for this week with pediatric patients.
– Did you face any challenges, any success? If so, what were they?
– Describe the assessment of a patient, detailing the signs and symptoms (S&S), assessment, plan of care, and at least 3 possible differential diagnosis with rationales.
– Mention the health promotion intervention for this patient.
– What did you learn from this week's clinical experience that can beneficial for you as an advanced practice nurse?
– Support your plan of care with the current peer-reviewed research guideline.
**Submission Instructions:**
– Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources published within the last five years.
– 2 years ago
List strategies that might be used by a pediatric primary care provider to incorporate developmental anticipatory guidance into the following sick visits: 1. An 18-month-old with an acute upper respiratory infection 2. A 4-year-old with stool withholding and constipation 3. A 9-year-old with chronic…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →List strategies that might be used by a pediatric primary care provider to incorporate developmental anticipatory guidance into the following sick visits:
1. An 18-month-old with an acute upper respiratory infection
2. A 4-year-old with stool withholding and constipation
3. A 9-year-old with chronic headaches
4. A 15-year-old with dysmenorrhea.
**Submission Instructions:**
– Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources published within the last five years.
– 2 years ago
The use of spirituality in nursing practice is not new. However, it is more studied and utilized in a more structured format in nursing. Identify and discuss tools used to evaluate spirituality. Please include 400 words in your initial post with two scholarly articles by Wednesday midnight and 200 w…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →The use of spirituality in nursing practice is not new. However, it is more studied and utilized in a more structured format in nursing. Identify and discuss tools used to evaluate spirituality.
Please include 400 words in your initial post with two scholarly articles by Wednesday midnight and 200 words in two answers to your peers by Saturday midnight.
– 2 years ago
– 2 years ago **files (1)** – ## ArabDiscussion.docx **## ArabDiscussion.docx** **Please follow APA format, add citations and references. Document will be verified for plagiarism and AI use. Thank you!** **Arab Discussion** Mrs. Nasser arrived at the urgent-care center with her 16-year-old daughter,…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →– 2 years ago
**files (1)**
– ## ArabDiscussion.docx
**## ArabDiscussion.docx**
**Please follow APA format, add citations and references. Document will be verified for plagiarism and AI use. Thank you!**
**Arab Discussion**
Mrs. Nasser arrived at the urgent-care center with her 16-year-old daughter, who had been experiencing burning upon urination, itching around her genital area, and a high fever. Mrs. Nasser appeared very anxious, explaining to the nurse that her daughter had never had these symptoms before. The nurse tried to calm Mrs. Nasser and asked that her daughter, Samia, get undressed in preparation for a physical examination. Mrs. Nasser appeared concerned and requested that the nurse inform the doctor that she will not allow the doctor to perform a vaginal examination on her daughter.
The nurse explained to Mrs. Nasser that it will be necessary for the doctor to examine Samia so that she can determine the cause of Samia’s discomfort. Mrs. Nasser became extremely agitated and explained to the nurse that in her culture, young girls are not allowed to have a vaginal examination for fear that their virginity will be compromised. Mrs. Nasser insisted that she would not allow her daughter to be examined by the female doctor on duty. Mrs. Nasser requested that the nurse ask the doctor to write a prescription for her daughter’s infection, or else she would leave the clinic immediately.
1. How should the nurse respond to Mrs. Nasser’s request? Explain your rationale.
2. Identify culturally congruent strategies that may be most effective in addressing the needs of Mrs. Nasser.
3. How might the nurse ensure that Mrs. Nasser’s concerns are addressed appropriately and that Samia has received the appropriate care?
**## ArabDiscussion.docx**
**Please follow APA format, add citations and references. Document will be verified for plagiarism and AI use. Thank you!**
**Arab Discussion**
Mrs. Nasser arrived at the urgent-care center with her 16-year-old daughter, who had been experiencing burning upon urination, itching around her genital area, and a high fever. Mrs. Nasser appeared very anxious, explaining to the nurse that her daughter had never had these symptoms before. The nurse tried to calm Mrs. Nasser and asked that her daughter, Samia, get undressed in preparation for a physical examination. Mrs. Nasser appeared concerned and requested that the nurse inform the doctor that she will not allow the doctor to perform a vaginal examination on her daughter.
The nurse explained to Mrs. Nasser that it will be necessary for the doctor to examine Samia so that she can determine the cause of Samia’s discomfort. Mrs. Nasser became extremely agitated and explained to the nurse that in her culture, young girls are not allowed to have a vaginal examination for fear that their virginity will be compromised. Mrs. Nasser insisted that she would not allow her daughter to be examined by the female doctor on duty. Mrs. Nasser requested that the nurse ask the doctor to write a prescription for her daughter’s infection, or else she would leave the clinic immediately.
1. How should the nurse respond to Mrs. Nasser’s request? Explain your rationale.
2. Identify culturally congruent strategies that may be most effective in addressing the needs of Mrs. Nasser.
3. How might the nurse ensure that Mrs. Nasser’s concerns are addressed appropriately and that Samia has received the appropriate care?
– 2 years ago **files (1)** – ## PolicyandPoliticsinHealthcareOrganizations.docx **## PolicyandPoliticsinHealthcareOrganizations.docx** _Policy and Politics in Healthcare Organizations_ Instructions: How can policies and politics affect a Healthcare Organization and Nursing academia? Contribute a mi…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →– 2 years ago
**files (1)**
– ## PolicyandPoliticsinHealthcareOrganizations.docx
**## PolicyandPoliticsinHealthcareOrganizations.docx**
_Policy and Politics in Healthcare Organizations_
Instructions:
How can policies and politics affect a Healthcare Organization and Nursing academia?
Contribute a minimum of 5-6 pages. It should include at least 3 academic sources, formatted and cited in APA.
Be sure to review the
[academic expectations](https://agmu.instructure.com/courses/1876/pages/expectations-and-best-practices-for-assignments) for your submission.
**Submission Instructions:**
**Excellent**
The student meets 90% to 100% of the required content criteria by mastering both rudimentary and complex elements and, in addition, applying high-level facts, theories, definitions, and other contextual aspects. Lastly, all the delivered information is compliant with the assignment instructions.
Critical and Logical Thinking
Thought analysis process
The assignment meets 90% to 100% of rudimentary and complex details, situations, problems, and diagnosis awareness that are accurate and correctly documented. In addition, the analysis offers a clear and concise analysis along with an impeccable and precise, well-thought process.
**## PolicyandPoliticsinHealthcareOrganizations.docx**
_Policy and Politics in Healthcare Organizations_
Instructions:
How can policies and politics affect a Healthcare Organization and Nursing academia?
Contribute a minimum of 5-6 pages. It should include at least 3 academic sources, formatted and cited in APA.
Be sure to review the
[academic expectations](https://agmu.instructure.com/courses/1876/pages/expectations-and-best-practices-for-assignments) for your submission.
**Submission Instructions:**
**Excellent**
The student meets 90% to 100% of the required content criteria by mastering both rudimentary and complex elements and, in addition, applying high-level facts, theories, definitions, and other contextual aspects. Lastly, all the delivered information is compliant with the assignment instructions.
Critical and Logical Thinking
Thought analysis process
The assignment meets 90% to 100% of rudimentary and complex details, situations, problems, and diagnosis awareness that are accurate and correctly documented. In addition, the analysis offers a clear and concise analysis along with an impeccable and precise, well-thought process.
– 2 years ago **files (1)** – ## module2PHARMDISCUSSION.docx **## module2PHARMDISCUSSION.docx** **_Describing, Diagnosing, & Treatment of Skin, Eye, & Ear Disorders_** Based on [Module 2: Lecture Materials & Resources](https://…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →– 2 years ago
**files (1)**
– ## module2PHARMDISCUSSION.docx
**## module2PHARMDISCUSSION.docx**
**_Describing, Diagnosing, & Treatment of Skin, Eye, & Ear Disorders_**
Based on
[Module 2: Lecture Materials & Resources](https://stu.instructure.com/courses/44860/pages/module-2-lecture-materials-and-resources?wrap=1) and experience, please answer the following questions:
1. Describe dermatitis, diagnostic criteria, and treatment modalities
2. Describe the drug therapy for Conjunctivitis and Otitis Media
3. Discuss Herpes Virus infections, patient presentation, and treatment
4. Describe the most common primary bacterial skin infections and the treatment of choice.
**Submission Instructions:**
· Your initial post must be at least 500 words, formatted, and cited in current APA style with support from at least two academic sources.
Each question must be answered individually as in bullet points. Not in an essay format. Example: Question 1, followed by the answer to question 1; Question 2, followed by the answer to question 2; and so forth.
· Each question
**must be answered individually** as in bullet points.
**Not** in an essay format.
· Quotes “……” cannot be used at a higher learning level for your assignments, so sentences need to be paraphrased and referenced.
· Acceptable references include scholarly journal articles or primary legal sources (statutes, court opinions), journal articles, and books published in the last five years-no websites to be referenced without prior approval.
## image1.png
**## module2PHARMDISCUSSION.docx**
**_Describing, Diagnosing, & Treatment of Skin, Eye, & Ear Disorders_**
Based on
[Module 2: Lecture Materials & Resources](https://stu.instructure.com/courses/44860/pages/module-2-lecture-materials-and-resources?wrap=1) and experience, please answer the following questions:
1. Describe dermatitis, diagnostic criteria, and treatment modalities
2. Describe the drug therapy for Conjunctivitis and Otitis Media
3. Discuss Herpes Virus infections, patient presentation, and treatment
4. Describe the most common primary bacterial skin infections and the treatment of choice.
**Submission Instructions:**
· Your initial post must be at least 500 words, formatted, and cited in current APA style with support from at least two academic sources.
Each question must be answered individually as in bullet points. Not in an essay format. Example: Question 1, followed by the answer to question 1; Question 2, followed by the answer to question 2; and so forth.
· Each question
**must be answered individually** as in bullet points.
**Not** in an essay format.
· Quotes “……” cannot be used at a higher learning level for your assignments, so sentences need to be paraphrased and referenced.
· Acceptable references include scholarly journal articles or primary legal sources (statutes, court opinions), journal articles, and books published in the last five years-no websites to be referenced without prior approval.
## image1.png
us esoap note template attached other is just instructions – 2 years ago **files (2)** – ## soapnoteinstructions.docx – ## soapmodule2.docx **## soapnoteinstructions.docx** 1. Compose a written comprehensive psychiatric evaluation of a patient you have seen in the clinic. 2. Upload your completed …
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →us esoap note template attached other is just instructions
– 2 years ago
**files (2)**
– ## soapnoteinstructions.docx
– ## soapmodule2.docx
**## soapnoteinstructions.docx**
1. Compose a written comprehensive psychiatric evaluation of a patient you have seen in the clinic.
2. Upload your completed comprehensive psychiatric evaluation as a Word doc. Scanned PDFs will not be accepted.
·
**For the Comprehensive Psychiatric Evaluation Presentation Assignment:** You will need to get it signed by your preceptor for the presentation (actual signature, not electronically typed).
**Step 2:** Each student will create a focused SOAP note video presentation in the next assignment. See
[Comprehensive Psychiatric Evaluation Presentation 1](https://stu.instructure.com/courses/43967/assignments/579648?wrap=1) for more details.
SOAP is an acronym that stands for Subjective, Objective, Assessment, and Plan.
**S =**
Subjective data: Patient’s Chief Complaint (CC); History of the Present Illness (HPI)/ Demographics; History of the Present Illness (HPI) that includes the presenting problem and the 8 dimensions of the problem (OLDCARTS or PQRST); Review of Systems (ROS)
**O =**
Objective data: Medications; Allergies; Past medical history; Family psychiatric history; Past surgical history; Psychiatric history, Social history; Labs and screening tools; Vital signs; Physical exam, (Focused), and Mental Status Exam
**A =**
Assessment: Primary Diagnosis and two differential diagnoses including ICD-10 and DSM5 codes
**P =**
Plan: Pharmacologic and Non-pharmacologic treatment plan; diagnostic testing/screening tools, patient/family teaching, referral, and follow up
**Other:** Incorporate current clinical guidelines
[NIH Clinical GuidelinesLinks to an external site.](https://www.nccih.nih.gov/health/providers/clinicalpractice) or
[APA Clinical GuidelinesLinks to an external site.](https://www.psychiatry.org/psychiatrists/practice/clinical-practice-guidelines), research articles, and the role of the PMHNP in your evaluation.
atatched is the soap note template use apa 7 the dition
**## soapmodule2.docx**
"Thank you for sharing your perspective on how Haitian culture views the causes of psychological problems in children. I find it fascinating how different cultures interpret mental health through their own spiritual and traditional beliefs. Coming from a
**Latino background**, I can relate to some of these views, particularly the idea that spirituality and external forces can influence a child's well-being.
In Latino culture, many families also attribute
**mental and emotional struggles** in children to
**spiritual or supernatural causes**, such as
**"mal de ojo" (the evil eye)** or
**negative energies** from others. It’s common for parents to seek help from religious figures, such as priests or healers, before turning to medical professionals. Similarly to the Haitian perspective, many believe that emotional distress can result from a
**disruption in spiritual balance**, leading families to use prayer, religious rituals, or traditional healing methods as a way to protect and restore a child's well-being.
However, alongside these spiritual beliefs, there is a growing recognition within Latino communities of the
**biological and psychological factors** that contribute to childhood mental health issues. In recent years, more families have begun to accept that
**trauma, family dynamics, social pressures, and even genetics** play a significant role in a child's psychological development. Mental health stigma still exists, but there is increasing awareness of the importance of therapy and medical intervention when needed.
I appreciate how your
**Haitian background emphasizes spirituality and supernatural experiences** as key influences on a child's mental health. While my Latino upbringing shares some of these traditional beliefs, it also integrates a
**strong emphasis on family dynamics, emotional expression, and the impact of life stressors** in understanding childhood psychological struggles.
It’s interesting to see how both cultures deeply value
**community, family, and faith** when addressing mental health, even if the explanations may differ. I think conversations like these are essential in bridging cultural perspectives and helping us become more culturally competent healthcare providers. Thank you for sharing your insights—I truly enjoyed learning about the Haitian perspective on child psychology!"*
**## soapmodule2.docx**
"Thank you for sharing your perspective on how Haitian culture views the causes of psychological problems in children. I find it fascinating how different cultures interpret mental health through their own spiritual and traditional beliefs. Coming from a
**Latino background**, I can relate to some of these views, particularly the idea that spirituality and external forces can influence a child's well-being.
In Latino culture, many families also attribute
**mental and emotional struggles** in children to
**spiritual or supernatural causes**, such as
**"mal de ojo" (the evil eye)** or
**negative energies** from others. It’s common for parents to seek help from religious figures, such as priests or healers, before turning to medical professionals. Similarly to the Haitian perspective, many believe that emotional distress can result from a
**disruption in spiritual balance**, leading families to use prayer, religious rituals, or traditional healing methods as a way to protect and restore a child's well-being.
However, alongside these spiritual beliefs, there is a growing recognition within Latino communities of the
**biological and psychological factors** that contribute to childhood mental health issues. In recent years, more families have begun to accept that
**trauma, family dynamics, social pressures, and even genetics** play a significant role in a child's psychological development. Mental health stigma still exists, but there is increasing awareness of the importance of therapy and medical intervention when needed.
I appreciate how your
**Haitian background emphasizes spirituality and supernatural experiences** as key influences on a child's mental health. While my Latino upbringing shares some of these traditional beliefs, it also integrates a
**strong emphasis on family dynamics, emotional expression, and the impact of life stressors** in understanding childhood psychological struggles.
It’s interesting to see how both cultures deeply value
**community, family, and faith** when addressing mental health, even if the explanations may differ. I think conversations like these are essential in bridging cultural perspectives and helping us become more culturally competent healthcare providers. Thank you for sharing your insights—I truly enjoyed learning about the Haitian perspective on child psychology!"*
**## soapnoteinstructions.docx**
1. Compose a written comprehensive psychiatric evaluation of a patient you have seen in the clinic.
2. Upload your completed comprehensive psychiatric evaluation as a Word doc. Scanned PDFs will not be accepted.
·
**For the Comprehensive Psychiatric Evaluation Presentation Assignment:** You will need to get it signed by your preceptor for the presentation (actual signature, not electronically typed).
**Step 2:** Each student will create a focused SOAP note video presentation in the next assignment. See
[Comprehensive Psychiatric Evaluation Presentation 1](https://stu.instructure.com/courses/43967/assignments/579648?wrap=1) for more details.
SOAP is an acronym that stands for Subjective, Objective, Assessment, and Plan.
**S =**
Subjective data: Patient’s Chief Complaint (CC); History of the Present Illness (HPI)/ Demographics; History of the Present Illness (HPI) that includes the presenting problem and the 8 dimensions of the problem (OLDCARTS or PQRST); Review of Systems (ROS)
**O =**
Objective data: Medications; Allergies; Past medical history; Family psychiatric history; Past surgical history; Psychiatric history, Social history; Labs and screening tools; Vital signs; Physical exam, (Focused), and Mental Status Exam
**A =**
Assessment: Primary Diagnosis and two differential diagnoses including ICD-10 and DSM5 codes
**P =**
Plan: Pharmacologic and Non-pharmacologic treatment plan; diagnostic testing/screening tools, patient/family teaching, referral, and follow up
**Other:** Incorporate current clinical guidelines
[NIH Clinical GuidelinesLinks to an external site.](https://www.nccih.nih.gov/health/providers/clinicalpractice) or
[APA Clinical GuidelinesLinks to an external site.](https://www.psychiatry.org/psychiatrists/practice/clinical-practice-guidelines), research articles, and the role of the PMHNP in your evaluation.
atatched is the soap note template use apa 7 the dition
**## soapmodule2.docx**
"Thank you for sharing your perspective on how Haitian culture views the causes of psychological problems in children. I find it fascinating how different cultures interpret mental health through their own spiritual and traditional beliefs. Coming from a
**Latino background**, I can relate to some of these views, particularly the idea that spirituality and external forces can influence a child's well-being.
In Latino culture, many families also attribute
**mental and emotional struggles** in children to
**spiritual or supernatural causes**, such as
**"mal de ojo" (the evil eye)** or
**negative energies** from others. It’s common for parents to seek help from religious figures, such as priests or healers, before turning to medical professionals. Similarly to the Haitian perspective, many believe that emotional distress can result from a
**disruption in spiritual balance**, leading families to use prayer, religious rituals, or traditional healing methods as a way to protect and restore a child's well-being.
However, alongside these spiritual beliefs, there is a growing recognition within Latino communities of the
**biological and psychological factors** that contribute to childhood mental health issues. In recent years, more families have begun to accept that
**trauma, family dynamics, social pressures, and even genetics** play a significant role in a child's psychological development. Mental health stigma still exists, but there is increasing awareness of the importance of therapy and medical intervention when needed.
I appreciate how your
**Haitian background emphasizes spirituality and supernatural experiences** as key influences on a child's mental health. While my Latino upbringing shares some of these traditional beliefs, it also integrates a
**strong emphasis on family dynamics, emotional expression, and the impact of life stressors** in understanding childhood psychological struggles.
It’s interesting to see how both cultures deeply value
**community, family, and faith** when addressing mental health, even if the explanations may differ. I think conversations like these are essential in bridging cultural perspectives and helping us become more culturally competent healthcare providers. Thank you for sharing your insights—I truly enjoyed learning about the Haitian perspective on child psychology!"*
**## soapnoteinstructions.docx**
1. Compose a written comprehensive psychiatric evaluation of a patient you have seen in the clinic.
2. Upload your completed comprehensive psychiatric evaluation as a Word doc. Scanned PDFs will not be accepted.
·
**For the Comprehensive Psychiatric Evaluation Presentation Assignment:** You will need to get it signed by your preceptor for the presentation (actual signature, not electronically typed).
**Step 2:** Each student will create a focused SOAP note video presentation in the next assignment. See
[Comprehensive Psychiatric Evaluation Presentation 1](https://stu.instructure.com/courses/43967/assignments/579648?wrap=1) for more details.
SOAP is an acronym that stands for Subjective, Objective, Assessment, and Plan.
**S =**
Subjective data: Patient’s Chief Complaint (CC); History of the Present Illness (HPI)/ Demographics; History of the Present Illness (HPI) that includes the presenting problem and the 8 dimensions of the problem (OLDCARTS or PQRST); Review of Systems (ROS)
**O =**
Objective data: Medications; Allergies; Past medical history; Family psychiatric history; Past surgical history; Psychiatric history, Social history; Labs and screening tools; Vital signs; Physical exam, (Focused), and Mental Status Exam
**A =**
Assessment: Primary Diagnosis and two differential diagnoses including ICD-10 and DSM5 codes
**P =**
Plan: Pharmacologic and Non-pharmacologic treatment plan; diagnostic testing/screening tools, patient/family teaching, referral, and follow up
**Other:** Incorporate current clinical guidelines
[NIH Clinical GuidelinesLinks to an external site.](https://www.nccih.nih.gov/health/providers/clinicalpractice) or
[APA Clinical GuidelinesLinks to an external site.](https://www.psychiatry.org/psychiatrists/practice/clinical-practice-guidelines), research articles, and the role of the PMHNP in your evaluation.
atatched is the soap note template use apa 7 the dition
**## soapmodule2.docx**
"Thank you for sharing your perspective on how Haitian culture views the causes of psychological problems in children. I find it fascinating how different cultures interpret mental health through their own spiritual and traditional beliefs. Coming from a
**Latino background**, I can relate to some of these views, particularly the idea that spirituality and external forces can influence a child's well-being.
In Latino culture, many families also attribute
**mental and emotional struggles** in children to
**spiritual or supernatural causes**, such as
**"mal de ojo" (the evil eye)** or
**negative energies** from others. It’s common for parents to seek help from religious figures, such as priests or healers, before turning to medical professionals. Similarly to the Haitian perspective, many believe that emotional distress can result from a
**disruption in spiritual balance**, leading families to use prayer, religious rituals, or traditional healing methods as a way to protect and restore a child's well-being.
However, alongside these spiritual beliefs, there is a growing recognition within Latino communities of the
**biological and psychological factors** that contribute to childhood mental health issues. In recent years, more families have begun to accept that
**trauma, family dynamics, social pressures, and even genetics** play a significant role in a child's psychological development. Mental health stigma still exists, but there is increasing awareness of the importance of therapy and medical intervention when needed.
I appreciate how your
**Haitian background emphasizes spirituality and supernatural experiences** as key influences on a child's mental health. While my Latino upbringing shares some of these traditional beliefs, it also integrates a
**strong emphasis on family dynamics, emotional expression, and the impact of life stressors** in understanding childhood psychological struggles.
It’s interesting to see how both cultures deeply value
**community, family, and faith** when addressing mental health, even if the explanations may differ. I think conversations like these are essential in bridging cultural perspectives and helping us become more culturally competent healthcare providers. Thank you for sharing your insights—I truly enjoyed learning about the Haitian perspective on child psychology!"*
**Hematopoietic:** J.D. is a 37 years old white woman who presents to her gynecologist complaining of a 2-month history of intermenstrual bleeding, menorrhagia, increased urinary frequency, mild incontinence, extreme fatigue, and weakness. Her menstrual period occurs every 28 days and lately there h…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →**Hematopoietic:**
J.D. is a 37 years old white woman who presents to her gynecologist complaining of a 2-month history of intermenstrual bleeding, menorrhagia, increased urinary frequency, mild incontinence, extreme fatigue, and weakness. Her menstrual period occurs every 28 days and lately there have been 6 days of heavy flow and cramping. She denies abdominal distension, back-ache, and constipation. She has not had her usual energy levels since before her last pregnancy.
**Past Medical History (PMH):**
Upon reviewing her past medical history, the gynecologist notes that her patient is a G5P5with four pregnancies within four years, the last infant having been delivered vaginally four months ago. All five pregnancies were unremarkable and without delivery complications. All infants were born healthy. Patient history also reveals a 3-year history of osteoarthritis in the left knee, probably the result of sustaining significant trauma to her knee in an MVA when she was 9 years old. When asked what OTC medications she is currently taking for her pain and for how long she has been taking them, she reveals that she started taking ibuprofen, three tablets each day, about 2.5 years ago for her left knee. Due to a slowly progressive increase in pain and a loss of adequate relief with three tablets, she doubled the daily dose of ibuprofen. Upon the recommendation from her nurse practitioner and because long-term ibuprofen use can cause peptic ulcers, she began taking OTC omeprazole on a regular basis to prevent gastrointestinal bleeding. Patient history also reveals a 3-year history of HTN for which she is now being treated with a diuretic and a centrally acting antihypertensive drug. She has had no previous surgeries.
**Case Study Questions**
1. Name the contributing factors on J.D that might put her at risk to develop iron deficiency anemia.
2. Within the case study, describe the reasons why J.D. might be presenting constipation and or dehydration.
3. Why Vitamin B12 and folic acid are important on the erythropoiesis? What abnormalities their deficiency might cause on the red blood cells?
4. The gynecologist is suspecting that J.D. might be experiencing iron deficiency anemia.
In order to support the diagnosis, list and describe the clinical symptoms that J.D. might have positive for Iron deficiency anemia.
5. If the patient is diagnosed with iron deficiency anemia, what do you expect to find as signs of this type of anemia? List and describe.
6. Labs results came back for the patient. Hb 10.2 g/dL; Hct 30.8%; Ferritin 9 ng/dL; red blood cells are smaller and paler in color than normal. Research list and describe for appropriate recommendations and treatments for J.D.
– 2 years ago
– 2 years ago **files (2)** – ## Thisisthesecondpartandprofessorfeedbackoffirstpart.docx – ## AtrialFibrillationandPortableECGinDiagnosisandMonitoring.docx **## Thisisthesecondpartandprofessorfeedbackoffirstpart.docx** **This is the second part and professor feedback of first part** **Feedback** Goo…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →– 2 years ago
**files (2)**
– ## Thisisthesecondpartandprofessorfeedbackoffirstpart.docx
– ## AtrialFibrillationandPortableECGinDiagnosisandMonitoring.docx
**## Thisisthesecondpartandprofessorfeedbackoffirstpart.docx**
**This is the second part and professor feedback of first part**
**Feedback** Good discussion. Please be more specific with your outcomes results when discussing hoe the tool chosen improve population outcomes."
**Chosen Evidence-Based Technology Use in Disease or Risk Factor**
-Describe and summarize the evidence-based technology identified that has been shown to improve the condition or Risk Factor for your patient population chosen.
-Compare and contrast the positives and negatives of using this technology use chosen.
**Conclusion**
-Recap points discussed in the paper
-Importance of advancements in technology
**Signature Assignment. Submit the complete paper including the conclusion**
Completion requirements
**Opened:** Monday, March 24, 2025, 11:00 AM
**Due:** Sunday, March 30, 2025, 11:00 PM
Full description of the assignment is included at the end of the syllabus.
In this section the students needs to submit a complete assignment. Which includes: Introduction, Body and Conclusion.
Introduction:
**Introduction:**
Brief overview of the health of the population chosen
-Introduce the global burden of disease OR risk factor chosen
-Importance of improving the condition and its impact on quality of life
**Body of the Paper**
**Global Burden of Disease Condition/Risk Factor**
-Describe the disease OR risk factor chosen
-What signs/symptoms are identified in the patient that can be found?
-How is it diagnosed and treated?
**Technology and Healthcare**
-Describe the paradigm shift in healthcare related to technology
-Elaborate how technology can improve health outcomes in your population
**## AtrialFibrillationandPortableECGinDiagnosisandMonitoring.docx**
5
**Atrial Fibrillation and Portable ECG in Diagnosis and Monitoring**
Name of Student
Lecturer Name
Course
Date
**Atrial Fibrillation and Portable ECG in Diagnosis and Monitoring**
**Introduction**
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, affects millions of people and is an important cause of morbidity and mortality. The adult population, particularly those over 65, faces an increasing prevalence of AF due to aging, comorbidities, and lifestyle factors. AF increases the risk of stroke, heart failure and additional cardiovascular complications greatly and early detection of AF is imperative in reducing its risk. AF also carries a significant health and economic burden for other than individual health. For the sake of the improvement of patient outcomes, effective diagnosis and a continuous monitoring have to be achieved and that is achievable through the use of the technology such as the portable electrocardiogram (ECG) devices. This paper describes the global AF burden, AF clinical presentation and the paradigm shift in healthcare technology enabled by the advent of portable ECG devices assessing their impact on patient outcomes.
**Global Burden of Disease Condition**
Atrial fibrillation is a growing public health issue with increasing worldwide prevalence and incidence. AF affects over 46 million people worldwide according to the Global Burden of Disease study, and it is projected to increase with aging and prevalence of risk factors (Kornej et al., 2020). It is estimated that, in the US alone, the number of people who have AF will be 12.1 million by 2030 (CDC, 2024). AF is more likely to develop in older individuals with 6.4% prevalence at age 65–69 and 28.5% in those above 85 years (Khurshid et al., 2023). Additionally, AF is associated with increased healthcare utilization in the form of increased rates of hospitalization, emergency room visits, and an increased risk of ischemic stroke (Joglar et al., 2023).
AF has a wide range of clinical presentation from asymptomatic to severe with palpitations, dyspnea, fatigue, dizziness, chest pain (CDC, 2024). Most episodes are paroxysmal, many of which are not detected and so are missed or delayed diagnosis leading to an enhanced risk of complication thromboembolism. However, intermittent, often asymptomatic presentations often require prolonged rhythm monitoring that places it as the gold standard for diagnosis. According to current guidelines, stroke risk stratification should use the CHA2DS2-VASc score and anticoagulation therapy for high risk patients (Joglar et al., 2023). Treatment options include rate and rhythm control with medications including beta blockers, electrical cardioversion and catheter ablation, and lifestyle modifications. However, there is a lack of timely and effective monitoring; and technological innovation is needed to facilitate improved detection and management of the disease.
**Technology and Healthcare**
The introduction of digital health technologies has shaped the healthcare in a great way. Portable ECG devices are great examples of the shift toward patient centered care as they enable real time monitoring, early detection and improved disease management. Because the devices are so capable of detecting AF outside of traditional clinical settings, patients with intermittent arrhythmias who would otherwise go undiagnosed are of particular relevance (Brandes et al., 2022). This aligns with the broader movement of digital medicine through the shift towards wearable and mobile health technologies which allow for continuous monitoring for the purposes of developing personalized treatment plans and proactive interventions.
There are a number of benefits of integrating portable ECGs into clinical practice, such as increased diagnostic yield, improved patient engagement, and possible cost savings from decreased hospitalizations and emergency visits (Aljuaid et al., 2020). However, there remains doubt about the accuracy, reliability and interpretation of consumer-driven ECG readings from the public. While some AF studies have reported high sensitivity and specificity in detecting AF, challenges including false positives, the need for physician confirmation, and integration with electronic health records remain (Brandes et al., 2022). Complicating further widespread adoption are regulatory oversight, data privacy concerns, as well as disparities in access to technology. However, portable ECGs are increasingly used as an important asset of AF management, along with traditional diagnostic techniques and to improve patient outcomes.
**Chosen Evidence-Based Technology Use in Disease**
Portable ECG devices have shown a great deal of potential for improving detection and monitoring of AF. Real time rhythm assessment ECG devices incorporate single or multi lead ECG technology with incorporated smartphone apps. Research have indicated that the portable ECGs, like KardiaMobile and Apple Watch, have high sensitivity (96%) and specificity (92%) in detecting AF (Pearson 2022). The devices enable on demand ECG recording whereby patients can record arrhythmic episodes when they happen for improved diagnostic accuracy compared to regular intermittent monitoring.
Portable ECG use has been linked to better clinical outcomes including fewer emergency department visits and hospitalizations. Aljuaid et al. (2020) found that patients using smartphone based ECG monitor in comparison to the patients relying on traditional event monitor have significantly fewer clinic visits and emergency room admissions. In addition, the ability to perform continuous remote monitoring allows for timely correction of anticoagulation and antirrythmic therapy and eliminates the risk of stroke and of complications of AF (Joglar et al., 2023). Portable ECG technology is thus transformative: its ability to enable real-time data, that leads to the potential to intervene early and with personalized treatment, is a major advance in this area.
Despite these advantages, limitations exist. This could lead to unnecessary anxiety and excessive healthcare utilization through false positives. Workflow difficulties in clinical practice arise from the need for physician confirmation of automated interpretations. Further, there may be cost and accessibility issues that impact widespread adoption, especially with socioeconomically disadvantaged populations (Brandes et al., 2022). In order to address these barriers, healthcare providers, technology developers and policymakers must work together to ensure that implementation is optimized and benefits are maximized.
**Conclusion**
Atrial fibrillation is a major source of global health burden, and particularly so among the aging adult population. The ability to detect and monitor continuously is crucial for reducing complications and enhancing patient outcomes. AF diagnosis and management has been contributed by portable ECG technology, a useful tool for real-time rhythm assessment, early detection and remote monitoring. These devices provide great advantages but these devices still have to address challenges of accuracy, integration into clinical workflows and accessibility. In the coming years, the future of arrhythmia care will be shaped in large part by the continued advancement of digital health technologies and their incorporation into guideline based AF management. By combining portables ECGs with the standard monitoring approach, AF detection can be further improved, optimal treatment can be achieved, and disease burden can be reduced.
**References**
Aljuaid, M., Marashly, Q., AlDanaf, J., Tawhari, I., Barakat, M., Barakat, R., Zobell, B., Cho, W., Chelu, M. G., & Marrouche, N. F. (2020). Smartphone ECG monitoring system helps lower emergency room and clinic visits in post-atrial fibrillation ablation patients.
_Clinical Medicine Insights: Cardiology, 14_, 1-7. https://doi.org/10.1177/1179546820901508
Brandes, A., Stavrakis, S., Freedman, B., Antoniou, S., Boriani, G., Camm, A. J., Chow, C. K., Ding, E., Engdahl, J., Gibson, M. M., Golovchiner, G., Glotzer, T., Guo, Y., Healey, J. S., Hills, M. T., Johnson, L., Lip, G. Y. H., Lobban, T., Macfarlane, P. W., … Turakhia, M. P. (2022). Consumer-led screening for atrial fibrillation: Frontier review of the AF-SCREEN international collaboration.
_Circulation, 146_(1461-1474). https://doi.org/10.1161/CIRCULATIONAHA.121.058911
Centers for Disease Control and Prevention. (2024). About atrial fibrillation.
_CDC Heart Disease and Stroke Prevention._ Retrieved from
[https://www.cdc.gov/heart-disease/about/atrial-fibrillation.html](https://www.cdc.gov/heart-disease/about/atrial-fibrillation.html)
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., Gorenek, B., Hess, P. L., Hlatky, M., Hogan, G., Ibeh, C., Indik, J. H., Kido, K., Kusumoto, F., Link, M. S., … Van Wagoner, D. R. (2023). 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation.
_Journal of the American College of Cardiology, 83_(1), 109-279. https://doi.org/10.1016/j.jacc.2023.08.017
Khurshid, S., Ashburner, J. M., Ellinor, P. T., McManus, D. D., Atlas, S. J., Singer, D. E., & Lubitz, S. A. (2023). Prevalence and incidence of atrial fibrillation among older primary care patients.
_JAMA Network Open, 6_(2), e2255838. https://doi.org/10.1001/jamanetworkopen.2022.55838
Kornej, J., Börschel, C. S., Benjamin, E. J., & Schnabel, R. B. (2020). Epidemiology of atrial fibrillation in the 21st century.
_Circulation Research, 127_(4), 4-20.
[https://doi.org/10.1161/CIRCRESAHA.120.316340](https://doi.org/10.1161/CIRCRESAHA.120.316340)
Pearson, V. (2022). Mobile ECG monitoring for atrial fibrillation management: A literature review.
_International Journal of Advanced Health Science and Technology, 2_(1), 19-25.
[https://doi.org/10.35882/ijahst.v2i1.4](https://doi.org/10.35882/ijahst.v2i1.4)
**## AtrialFibrillationandPortableECGinDiagnosisandMonitoring.docx**
5
**Atrial Fibrillation and Portable ECG in Diagnosis and Monitoring**
Name of Student
Lecturer Name
Course
Date
**Atrial Fibrillation and Portable ECG in Diagnosis and Monitoring**
**Introduction**
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, affects millions of people and is an important cause of morbidity and mortality. The adult population, particularly those over 65, faces an increasing prevalence of AF due to aging, comorbidities, and lifestyle factors. AF increases the risk of stroke, heart failure and additional cardiovascular complications greatly and early detection of AF is imperative in reducing its risk. AF also carries a significant health and economic burden for other than individual health. For the sake of the improvement of patient outcomes, effective diagnosis and a continuous monitoring have to be achieved and that is achievable through the use of the technology such as the portable electrocardiogram (ECG) devices. This paper describes the global AF burden, AF clinical presentation and the paradigm shift in healthcare technology enabled by the advent of portable ECG devices assessing their impact on patient outcomes.
**Global Burden of Disease Condition**
Atrial fibrillation is a growing public health issue with increasing worldwide prevalence and incidence. AF affects over 46 million people worldwide according to the Global Burden of Disease study, and it is projected to increase with aging and prevalence of risk factors (Kornej et al., 2020). It is estimated that, in the US alone, the number of people who have AF will be 12.1 million by 2030 (CDC, 2024). AF is more likely to develop in older individuals with 6.4% prevalence at age 65–69 and 28.5% in those above 85 years (Khurshid et al., 2023). Additionally, AF is associated with increased healthcare utilization in the form of increased rates of hospitalization, emergency room visits, and an increased risk of ischemic stroke (Joglar et al., 2023).
AF has a wide range of clinical presentation from asymptomatic to severe with palpitations, dyspnea, fatigue, dizziness, chest pain (CDC, 2024). Most episodes are paroxysmal, many of which are not detected and so are missed or delayed diagnosis leading to an enhanced risk of complication thromboembolism. However, intermittent, often asymptomatic presentations often require prolonged rhythm monitoring that places it as the gold standard for diagnosis. According to current guidelines, stroke risk stratification should use the CHA2DS2-VASc score and anticoagulation therapy for high risk patients (Joglar et al., 2023). Treatment options include rate and rhythm control with medications including beta blockers, electrical cardioversion and catheter ablation, and lifestyle modifications. However, there is a lack of timely and effective monitoring; and technological innovation is needed to facilitate improved detection and management of the disease.
**Technology and Healthcare**
The introduction of digital health technologies has shaped the healthcare in a great way. Portable ECG devices are great examples of the shift toward patient centered care as they enable real time monitoring, early detection and improved disease management. Because the devices are so capable of detecting AF outside of traditional clinical settings, patients with intermittent arrhythmias who would otherwise go undiagnosed are of particular relevance (Brandes et al., 2022). This aligns with the broader movement of digital medicine through the shift towards wearable and mobile health technologies which allow for continuous monitoring for the purposes of developing personalized treatment plans and proactive interventions.
There are a number of benefits of integrating portable ECGs into clinical practice, such as increased diagnostic yield, improved patient engagement, and possible cost savings from decreased hospitalizations and emergency visits (Aljuaid et al., 2020). However, there remains doubt about the accuracy, reliability and interpretation of consumer-driven ECG readings from the public. While some AF studies have reported high sensitivity and specificity in detecting AF, challenges including false positives, the need for physician confirmation, and integration with electronic health records remain (Brandes et al., 2022). Complicating further widespread adoption are regulatory oversight, data privacy concerns, as well as disparities in access to technology. However, portable ECGs are increasingly used as an important asset of AF management, along with traditional diagnostic techniques and to improve patient outcomes.
**Chosen Evidence-Based Technology Use in Disease**
Portable ECG devices have shown a great deal of potential for improving detection and monitoring of AF. Real time rhythm assessment ECG devices incorporate single or multi lead ECG technology with incorporated smartphone apps. Research have indicated that the portable ECGs, like KardiaMobile and Apple Watch, have high sensitivity (96%) and specificity (92%) in detecting AF (Pearson 2022). The devices enable on demand ECG recording whereby patients can record arrhythmic episodes when they happen for improved diagnostic accuracy compared to regular intermittent monitoring.
Portable ECG use has been linked to better clinical outcomes including fewer emergency department visits and hospitalizations. Aljuaid et al. (2020) found that patients using smartphone based ECG monitor in comparison to the patients relying on traditional event monitor have significantly fewer clinic visits and emergency room admissions. In addition, the ability to perform continuous remote monitoring allows for timely correction of anticoagulation and antirrythmic therapy and eliminates the risk of stroke and of complications of AF (Joglar et al., 2023). Portable ECG technology is thus transformative: its ability to enable real-time data, that leads to the potential to intervene early and with personalized treatment, is a major advance in this area.
Despite these advantages, limitations exist. This could lead to unnecessary anxiety and excessive healthcare utilization through false positives. Workflow difficulties in clinical practice arise from the need for physician confirmation of automated interpretations. Further, there may be cost and accessibility issues that impact widespread adoption, especially with socioeconomically disadvantaged populations (Brandes et al., 2022). In order to address these barriers, healthcare providers, technology developers and policymakers must work together to ensure that implementation is optimized and benefits are maximized.
**Conclusion**
Atrial fibrillation is a major source of global health burden, and particularly so among the aging adult population. The ability to detect and monitor continuously is crucial for reducing complications and enhancing patient outcomes. AF diagnosis and management has been contributed by portable ECG technology, a useful tool for real-time rhythm assessment, early detection and remote monitoring. These devices provide great advantages but these devices still have to address challenges of accuracy, integration into clinical workflows and accessibility. In the coming years, the future of arrhythmia care will be shaped in large part by the continued advancement of digital health technologies and their incorporation into guideline based AF management. By combining portables ECGs with the standard monitoring approach, AF detection can be further improved, optimal treatment can be achieved, and disease burden can be reduced.
**References**
Aljuaid, M., Marashly, Q., AlDanaf, J., Tawhari, I., Barakat, M., Barakat, R., Zobell, B., Cho, W., Chelu, M. G., & Marrouche, N. F. (2020). Smartphone ECG monitoring system helps lower emergency room and clinic visits in post-atrial fibrillation ablation patients.
_Clinical Medicine Insights: Cardiology, 14_, 1-7. https://doi.org/10.1177/1179546820901508
Brandes, A., Stavrakis, S., Freedman, B., Antoniou, S., Boriani, G., Camm, A. J., Chow, C. K., Ding, E., Engdahl, J., Gibson, M. M., Golovchiner, G., Glotzer, T., Guo, Y., Healey, J. S., Hills, M. T., Johnson, L., Lip, G. Y. H., Lobban, T., Macfarlane, P. W., … Turakhia, M. P. (2022). Consumer-led screening for atrial fibrillation: Frontier review of the AF-SCREEN international collaboration.
_Circulation, 146_(1461-1474). https://doi.org/10.1161/CIRCULATIONAHA.121.058911
Centers for Disease Control and Prevention. (2024). About atrial fibrillation.
_CDC Heart Disease and Stroke Prevention._ Retrieved from
[https://www.cdc.gov/heart-disease/about/atrial-fibrillation.html](https://www.cdc.gov/heart-disease/about/atrial-fibrillation.html)
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., Gorenek, B., Hess, P. L., Hlatky, M., Hogan, G., Ibeh, C., Indik, J. H., Kido, K., Kusumoto, F., Link, M. S., … Van Wagoner, D. R. (2023). 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation.
_Journal of the American College of Cardiology, 83_(1), 109-279. https://doi.org/10.1016/j.jacc.2023.08.017
Khurshid, S., Ashburner, J. M., Ellinor, P. T., McManus, D. D., Atlas, S. J., Singer, D. E., & Lubitz, S. A. (2023). Prevalence and incidence of atrial fibrillation among older primary care patients.
_JAMA Network Open, 6_(2), e2255838. https://doi.org/10.1001/jamanetworkopen.2022.55838
Kornej, J., Börschel, C. S., Benjamin, E. J., & Schnabel, R. B. (2020). Epidemiology of atrial fibrillation in the 21st century.
_Circulation Research, 127_(4), 4-20.
[https://doi.org/10.1161/CIRCRESAHA.120.316340](https://doi.org/10.1161/CIRCRESAHA.120.316340)
Pearson, V. (2022). Mobile ECG monitoring for atrial fibrillation management: A literature review.
_International Journal of Advanced Health Science and Technology, 2_(1), 19-25.
[https://doi.org/10.35882/ijahst.v2i1.4](https://doi.org/10.35882/ijahst.v2i1.4)
**## Thisisthesecondpartandprofessorfeedbackoffirstpart.docx**
**This is the second part and professor feedback of first part**
**Feedback** Good discussion. Please be more specific with your outcomes results when discussing hoe the tool chosen improve population outcomes."
**Chosen Evidence-Based Technology Use in Disease or Risk Factor**
-Describe and summarize the evidence-based technology identified that has been shown to improve the condition or Risk Factor for your patient population chosen.
-Compare and contrast the positives and negatives of using this technology use chosen.
**Conclusion**
-Recap points discussed in the paper
-Importance of advancements in technology
**Signature Assignment. Submit the complete paper including the conclusion**
Completion requirements
**Opened:** Monday, March 24, 2025, 11:00 AM
**Due:** Sunday, March 30, 2025, 11:00 PM
Full description of the assignment is included at the end of the syllabus.
In this section the students needs to submit a complete assignment. Which includes: Introduction, Body and Conclusion.
Introduction:
**Introduction:**
Brief overview of the health of the population chosen
-Introduce the global burden of disease OR risk factor chosen
-Importance of improving the condition and its impact on quality of life
**Body of the Paper**
**Global Burden of Disease Condition/Risk Factor**
-Describe the disease OR risk factor chosen
-What signs/symptoms are identified in the patient that can be found?
-How is it diagnosed and treated?
**Technology and Healthcare**
-Describe the paradigm shift in healthcare related to technology
-Elaborate how technology can improve health outcomes in your population
**## AtrialFibrillationandPortableECGinDiagnosisandMonitoring.docx**
5
**Atrial Fibrillation and Portable ECG in Diagnosis and Monitoring**
Name of Student
Lecturer Name
Course
Date
**Atrial Fibrillation and Portable ECG in Diagnosis and Monitoring**
**Introduction**
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, affects millions of people and is an important cause of morbidity and mortality. The adult population, particularly those over 65, faces an increasing prevalence of AF due to aging, comorbidities, and lifestyle factors. AF increases the risk of stroke, heart failure and additional cardiovascular complications greatly and early detection of AF is imperative in reducing its risk. AF also carries a significant health and economic burden for other than individual health. For the sake of the improvement of patient outcomes, effective diagnosis and a continuous monitoring have to be achieved and that is achievable through the use of the technology such as the portable electrocardiogram (ECG) devices. This paper describes the global AF burden, AF clinical presentation and the paradigm shift in healthcare technology enabled by the advent of portable ECG devices assessing their impact on patient outcomes.
**Global Burden of Disease Condition**
Atrial fibrillation is a growing public health issue with increasing worldwide prevalence and incidence. AF affects over 46 million people worldwide according to the Global Burden of Disease study, and it is projected to increase with aging and prevalence of risk factors (Kornej et al., 2020). It is estimated that, in the US alone, the number of people who have AF will be 12.1 million by 2030 (CDC, 2024). AF is more likely to develop in older individuals with 6.4% prevalence at age 65–69 and 28.5% in those above 85 years (Khurshid et al., 2023). Additionally, AF is associated with increased healthcare utilization in the form of increased rates of hospitalization, emergency room visits, and an increased risk of ischemic stroke (Joglar et al., 2023).
AF has a wide range of clinical presentation from asymptomatic to severe with palpitations, dyspnea, fatigue, dizziness, chest pain (CDC, 2024). Most episodes are paroxysmal, many of which are not detected and so are missed or delayed diagnosis leading to an enhanced risk of complication thromboembolism. However, intermittent, often asymptomatic presentations often require prolonged rhythm monitoring that places it as the gold standard for diagnosis. According to current guidelines, stroke risk stratification should use the CHA2DS2-VASc score and anticoagulation therapy for high risk patients (Joglar et al., 2023). Treatment options include rate and rhythm control with medications including beta blockers, electrical cardioversion and catheter ablation, and lifestyle modifications. However, there is a lack of timely and effective monitoring; and technological innovation is needed to facilitate improved detection and management of the disease.
**Technology and Healthcare**
The introduction of digital health technologies has shaped the healthcare in a great way. Portable ECG devices are great examples of the shift toward patient centered care as they enable real time monitoring, early detection and improved disease management. Because the devices are so capable of detecting AF outside of traditional clinical settings, patients with intermittent arrhythmias who would otherwise go undiagnosed are of particular relevance (Brandes et al., 2022). This aligns with the broader movement of digital medicine through the shift towards wearable and mobile health technologies which allow for continuous monitoring for the purposes of developing personalized treatment plans and proactive interventions.
There are a number of benefits of integrating portable ECGs into clinical practice, such as increased diagnostic yield, improved patient engagement, and possible cost savings from decreased hospitalizations and emergency visits (Aljuaid et al., 2020). However, there remains doubt about the accuracy, reliability and interpretation of consumer-driven ECG readings from the public. While some AF studies have reported high sensitivity and specificity in detecting AF, challenges including false positives, the need for physician confirmation, and integration with electronic health records remain (Brandes et al., 2022). Complicating further widespread adoption are regulatory oversight, data privacy concerns, as well as disparities in access to technology. However, portable ECGs are increasingly used as an important asset of AF management, along with traditional diagnostic techniques and to improve patient outcomes.
**Chosen Evidence-Based Technology Use in Disease**
Portable ECG devices have shown a great deal of potential for improving detection and monitoring of AF. Real time rhythm assessment ECG devices incorporate single or multi lead ECG technology with incorporated smartphone apps. Research have indicated that the portable ECGs, like KardiaMobile and Apple Watch, have high sensitivity (96%) and specificity (92%) in detecting AF (Pearson 2022). The devices enable on demand ECG recording whereby patients can record arrhythmic episodes when they happen for improved diagnostic accuracy compared to regular intermittent monitoring.
Portable ECG use has been linked to better clinical outcomes including fewer emergency department visits and hospitalizations. Aljuaid et al. (2020) found that patients using smartphone based ECG monitor in comparison to the patients relying on traditional event monitor have significantly fewer clinic visits and emergency room admissions. In addition, the ability to perform continuous remote monitoring allows for timely correction of anticoagulation and antirrythmic therapy and eliminates the risk of stroke and of complications of AF (Joglar et al., 2023). Portable ECG technology is thus transformative: its ability to enable real-time data, that leads to the potential to intervene early and with personalized treatment, is a major advance in this area.
Despite these advantages, limitations exist. This could lead to unnecessary anxiety and excessive healthcare utilization through false positives. Workflow difficulties in clinical practice arise from the need for physician confirmation of automated interpretations. Further, there may be cost and accessibility issues that impact widespread adoption, especially with socioeconomically disadvantaged populations (Brandes et al., 2022). In order to address these barriers, healthcare providers, technology developers and policymakers must work together to ensure that implementation is optimized and benefits are maximized.
**Conclusion**
Atrial fibrillation is a major source of global health burden, and particularly so among the aging adult population. The ability to detect and monitor continuously is crucial for reducing complications and enhancing patient outcomes. AF diagnosis and management has been contributed by portable ECG technology, a useful tool for real-time rhythm assessment, early detection and remote monitoring. These devices provide great advantages but these devices still have to address challenges of accuracy, integration into clinical workflows and accessibility. In the coming years, the future of arrhythmia care will be shaped in large part by the continued advancement of digital health technologies and their incorporation into guideline based AF management. By combining portables ECGs with the standard monitoring approach, AF detection can be further improved, optimal treatment can be achieved, and disease burden can be reduced.
**References**
Aljuaid, M., Marashly, Q., AlDanaf, J., Tawhari, I., Barakat, M., Barakat, R., Zobell, B., Cho, W., Chelu, M. G., & Marrouche, N. F. (2020). Smartphone ECG monitoring system helps lower emergency room and clinic visits in post-atrial fibrillation ablation patients.
_Clinical Medicine Insights: Cardiology, 14_, 1-7. https://doi.org/10.1177/1179546820901508
Brandes, A., Stavrakis, S., Freedman, B., Antoniou, S., Boriani, G., Camm, A. J., Chow, C. K., Ding, E., Engdahl, J., Gibson, M. M., Golovchiner, G., Glotzer, T., Guo, Y., Healey, J. S., Hills, M. T., Johnson, L., Lip, G. Y. H., Lobban, T., Macfarlane, P. W., … Turakhia, M. P. (2022). Consumer-led screening for atrial fibrillation: Frontier review of the AF-SCREEN international collaboration.
_Circulation, 146_(1461-1474). https://doi.org/10.1161/CIRCULATIONAHA.121.058911
Centers for Disease Control and Prevention. (2024). About atrial fibrillation.
_CDC Heart Disease and Stroke Prevention._ Retrieved from
[https://www.cdc.gov/heart-disease/about/atrial-fibrillation.html](https://www.cdc.gov/heart-disease/about/atrial-fibrillation.html)
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., Gorenek, B., Hess, P. L., Hlatky, M., Hogan, G., Ibeh, C., Indik, J. H., Kido, K., Kusumoto, F., Link, M. S., … Van Wagoner, D. R. (2023). 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation.
_Journal of the American College of Cardiology, 83_(1), 109-279. https://doi.org/10.1016/j.jacc.2023.08.017
Khurshid, S., Ashburner, J. M., Ellinor, P. T., McManus, D. D., Atlas, S. J., Singer, D. E., & Lubitz, S. A. (2023). Prevalence and incidence of atrial fibrillation among older primary care patients.
_JAMA Network Open, 6_(2), e2255838. https://doi.org/10.1001/jamanetworkopen.2022.55838
Kornej, J., Börschel, C. S., Benjamin, E. J., & Schnabel, R. B. (2020). Epidemiology of atrial fibrillation in the 21st century.
_Circulation Research, 127_(4), 4-20.
[https://doi.org/10.1161/CIRCRESAHA.120.316340](https://doi.org/10.1161/CIRCRESAHA.120.316340)
Pearson, V. (2022). Mobile ECG monitoring for atrial fibrillation management: A literature review.
_International Journal of Advanced Health Science and Technology, 2_(1), 19-25.
[https://doi.org/10.35882/ijahst.v2i1.4](https://doi.org/10.35882/ijahst.v2i1.4)
**## Thisisthesecondpartandprofessorfeedbackoffirstpart.docx**
**This is the second part and professor feedback of first part**
**Feedback** Good discussion. Please be more specific with your outcomes results when discussing hoe the tool chosen improve population outcomes."
**Chosen Evidence-Based Technology Use in Disease or Risk Factor**
-Describe and summarize the evidence-based technology identified that has been shown to improve the condition or Risk Factor for your patient population chosen.
-Compare and contrast the positives and negatives of using this technology use chosen.
**Conclusion**
-Recap points discussed in the paper
-Importance of advancements in technology
**Signature Assignment. Submit the complete paper including the conclusion**
Completion requirements
**Opened:** Monday, March 24, 2025, 11:00 AM
**Due:** Sunday, March 30, 2025, 11:00 PM
Full description of the assignment is included at the end of the syllabus.
In this section the students needs to submit a complete assignment. Which includes: Introduction, Body and Conclusion.
Introduction:
**Introduction:**
Brief overview of the health of the population chosen
-Introduce the global burden of disease OR risk factor chosen
-Importance of improving the condition and its impact on quality of life
**Body of the Paper**
**Global Burden of Disease Condition/Risk Factor**
-Describe the disease OR risk factor chosen
-What signs/symptoms are identified in the patient that can be found?
-How is it diagnosed and treated?
**Technology and Healthcare**
-Describe the paradigm shift in healthcare related to technology
-Elaborate how technology can improve health outcomes in your population
**## AtrialFibrillationandPortableECGinDiagnosisandMonitoring.docx**
5
**Atrial Fibrillation and Portable ECG in Diagnosis and Monitoring**
Name of Student
Lecturer Name
Course
Date
**Atrial Fibrillation and Portable ECG in Diagnosis and Monitoring**
**Introduction**
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, affects millions of people and is an important cause of morbidity and mortality. The adult population, particularly those over 65, faces an increasing prevalence of AF due to aging, comorbidities, and lifestyle factors. AF increases the risk of stroke, heart failure and additional cardiovascular complications greatly and early detection of AF is imperative in reducing its risk. AF also carries a significant health and economic burden for other than individual health. For the sake of the improvement of patient outcomes, effective diagnosis and a continuous monitoring have to be achieved and that is achievable through the use of the technology such as the portable electrocardiogram (ECG) devices. This paper describes the global AF burden, AF clinical presentation and the paradigm shift in healthcare technology enabled by the advent of portable ECG devices assessing their impact on patient outcomes.
**Global Burden of Disease Condition**
Atrial fibrillation is a growing public health issue with increasing worldwide prevalence and incidence. AF affects over 46 million people worldwide according to the Global Burden of Disease study, and it is projected to increase with aging and prevalence of risk factors (Kornej et al., 2020). It is estimated that, in the US alone, the number of people who have AF will be 12.1 million by 2030 (CDC, 2024). AF is more likely to develop in older individuals with 6.4% prevalence at age 65–69 and 28.5% in those above 85 years (Khurshid et al., 2023). Additionally, AF is associated with increased healthcare utilization in the form of increased rates of hospitalization, emergency room visits, and an increased risk of ischemic stroke (Joglar et al., 2023).
AF has a wide range of clinical presentation from asymptomatic to severe with palpitations, dyspnea, fatigue, dizziness, chest pain (CDC, 2024). Most episodes are paroxysmal, many of which are not detected and so are missed or delayed diagnosis leading to an enhanced risk of complication thromboembolism. However, intermittent, often asymptomatic presentations often require prolonged rhythm monitoring that places it as the gold standard for diagnosis. According to current guidelines, stroke risk stratification should use the CHA2DS2-VASc score and anticoagulation therapy for high risk patients (Joglar et al., 2023). Treatment options include rate and rhythm control with medications including beta blockers, electrical cardioversion and catheter ablation, and lifestyle modifications. However, there is a lack of timely and effective monitoring; and technological innovation is needed to facilitate improved detection and management of the disease.
**Technology and Healthcare**
The introduction of digital health technologies has shaped the healthcare in a great way. Portable ECG devices are great examples of the shift toward patient centered care as they enable real time monitoring, early detection and improved disease management. Because the devices are so capable of detecting AF outside of traditional clinical settings, patients with intermittent arrhythmias who would otherwise go undiagnosed are of particular relevance (Brandes et al., 2022). This aligns with the broader movement of digital medicine through the shift towards wearable and mobile health technologies which allow for continuous monitoring for the purposes of developing personalized treatment plans and proactive interventions.
There are a number of benefits of integrating portable ECGs into clinical practice, such as increased diagnostic yield, improved patient engagement, and possible cost savings from decreased hospitalizations and emergency visits (Aljuaid et al., 2020). However, there remains doubt about the accuracy, reliability and interpretation of consumer-driven ECG readings from the public. While some AF studies have reported high sensitivity and specificity in detecting AF, challenges including false positives, the need for physician confirmation, and integration with electronic health records remain (Brandes et al., 2022). Complicating further widespread adoption are regulatory oversight, data privacy concerns, as well as disparities in access to technology. However, portable ECGs are increasingly used as an important asset of AF management, along with traditional diagnostic techniques and to improve patient outcomes.
**Chosen Evidence-Based Technology Use in Disease**
Portable ECG devices have shown a great deal of potential for improving detection and monitoring of AF. Real time rhythm assessment ECG devices incorporate single or multi lead ECG technology with incorporated smartphone apps. Research have indicated that the portable ECGs, like KardiaMobile and Apple Watch, have high sensitivity (96%) and specificity (92%) in detecting AF (Pearson 2022). The devices enable on demand ECG recording whereby patients can record arrhythmic episodes when they happen for improved diagnostic accuracy compared to regular intermittent monitoring.
Portable ECG use has been linked to better clinical outcomes including fewer emergency department visits and hospitalizations. Aljuaid et al. (2020) found that patients using smartphone based ECG monitor in comparison to the patients relying on traditional event monitor have significantly fewer clinic visits and emergency room admissions. In addition, the ability to perform continuous remote monitoring allows for timely correction of anticoagulation and antirrythmic therapy and eliminates the risk of stroke and of complications of AF (Joglar et al., 2023). Portable ECG technology is thus transformative: its ability to enable real-time data, that leads to the potential to intervene early and with personalized treatment, is a major advance in this area.
Despite these advantages, limitations exist. This could lead to unnecessary anxiety and excessive healthcare utilization through false positives. Workflow difficulties in clinical practice arise from the need for physician confirmation of automated interpretations. Further, there may be cost and accessibility issues that impact widespread adoption, especially with socioeconomically disadvantaged populations (Brandes et al., 2022). In order to address these barriers, healthcare providers, technology developers and policymakers must work together to ensure that implementation is optimized and benefits are maximized.
**Conclusion**
Atrial fibrillation is a major source of global health burden, and particularly so among the aging adult population. The ability to detect and monitor continuously is crucial for reducing complications and enhancing patient outcomes. AF diagnosis and management has been contributed by portable ECG technology, a useful tool for real-time rhythm assessment, early detection and remote monitoring. These devices provide great advantages but these devices still have to address challenges of accuracy, integration into clinical workflows and accessibility. In the coming years, the future of arrhythmia care will be shaped in large part by the continued advancement of digital health technologies and their incorporation into guideline based AF management. By combining portables ECGs with the standard monitoring approach, AF detection can be further improved, optimal treatment can be achieved, and disease burden can be reduced.
**References**
Aljuaid, M., Marashly, Q., AlDanaf, J., Tawhari, I., Barakat, M., Barakat, R., Zobell, B., Cho, W., Chelu, M. G., & Marrouche, N. F. (2020). Smartphone ECG monitoring system helps lower emergency room and clinic visits in post-atrial fibrillation ablation patients.
_Clinical Medicine Insights: Cardiology, 14_, 1-7. https://doi.org/10.1177/1179546820901508
Brandes, A., Stavrakis, S., Freedman, B., Antoniou, S., Boriani, G., Camm, A. J., Chow, C. K., Ding, E., Engdahl, J., Gibson, M. M., Golovchiner, G., Glotzer, T., Guo, Y., Healey, J. S., Hills, M. T., Johnson, L., Lip, G. Y. H., Lobban, T., Macfarlane, P. W., … Turakhia, M. P. (2022). Consumer-led screening for atrial fibrillation: Frontier review of the AF-SCREEN international collaboration.
_Circulation, 146_(1461-1474). https://doi.org/10.1161/CIRCULATIONAHA.121.058911
Centers for Disease Control and Prevention. (2024). About atrial fibrillation.
_CDC Heart Disease and Stroke Prevention._ Retrieved from
[https://www.cdc.gov/heart-disease/about/atrial-fibrillation.html](https://www.cdc.gov/heart-disease/about/atrial-fibrillation.html)
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., Gorenek, B., Hess, P. L., Hlatky, M., Hogan, G., Ibeh, C., Indik, J. H., Kido, K., Kusumoto, F., Link, M. S., … Van Wagoner, D. R. (2023). 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation.
_Journal of the American College of Cardiology, 83_(1), 109-279. https://doi.org/10.1016/j.jacc.2023.08.017
Khurshid, S., Ashburner, J. M., Ellinor, P. T., McManus, D. D., Atlas, S. J., Singer, D. E., & Lubitz, S. A. (2023). Prevalence and incidence of atrial fibrillation among older primary care patients.
_JAMA Network Open, 6_(2), e2255838. https://doi.org/10.1001/jamanetworkopen.2022.55838
Kornej, J., Börschel, C. S., Benjamin, E. J., & Schnabel, R. B. (2020). Epidemiology of atrial fibrillation in the 21st century.
_Circulation Research, 127_(4), 4-20.
[https://doi.org/10.1161/CIRCRESAHA.120.316340](https://doi.org/10.1161/CIRCRESAHA.120.316340)
Pearson, V. (2022). Mobile ECG monitoring for atrial fibrillation management: A literature review.
_International Journal of Advanced Health Science and Technology, 2_(1), 19-25.
[https://doi.org/10.35882/ijahst.v2i1.4](https://doi.org/10.35882/ijahst.v2i1.4)